CHAMPIONS ONCOLOGY, INC. Logo

CHAMPIONS ONCOLOGY, INC.

A CRO providing end-to-end solutions to accelerate oncology drug development.

CSBR | US

Overview

Corporate Details

ISIN(s):
US15870P3073
LEI:
549300O8WKLP8QEG5U47
Country:
United States of America
Address:
855 N. WOLFE STREET, 21205 BALTIMORE

Description

Champions Oncology, Inc. is a technology-enabled contract research organization (CRO) providing end-to-end solutions to accelerate oncology drug development. The company partners with pharmaceutical and biotechnology firms, offering a range of preclinical and clinical research services. Its core offering is an extensive, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models used for in vivo and ex vivo efficacy studies. These models are supported by a comprehensive multi-omic data platform that provides genomic, transcriptomic, and proteomic insights for model selection and biomarker discovery. Additionally, Champions Oncology operates as a clinical specialty laboratory, providing advanced analytical services such as high-complexity flow cytometry, next-generation sequencing, and histology to support clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 13:14
FORM 4
English 7.3 KB
2025-11-07 12:57
FORM 4
English 7.3 KB
2025-11-07 12:18
FORM 4
English 7.3 KB
2025-11-07 12:00
FORM 4
English 7.3 KB
2025-11-07 11:26
FORM 4
English 7.3 KB
2025-11-06 12:19
FORM 4
English 7.4 KB
2025-10-16 19:05
8-K
English 64.2 KB
2025-09-15 18:50
10-Q
English 1.0 MB
2025-09-15 18:47
8-K
English 145.2 KB
2025-08-22 17:21
DEFA14A
English 12.6 KB
2025-08-22 17:20
DEF 14A
English 780.6 KB
2025-07-23 19:01
10-K
English 1.4 MB
2025-07-23 18:11
8-K
English 148.6 KB
2025-07-21 15:49
8-K
English 188.7 KB
2025-04-02 18:20
FORM 4
English 7.0 KB

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.